The size of the qPCR Reagents Market in Europe was valued at USD 0.41 billion in 2019 and estimated to be growing at a CAGR of 9.21%, to reach USD 0.6 billion by 2024 during the forecast period 2019-2024.
A qPCR also known as real-time polymerase chain reaction is a lab method of molecular biology, that works via polymerase chain reaction. QPCR screens the magnification of a specific DNA segment undergoing polymerase chain reaction. It can be applied in two variations, the semi-quantitative real-time polymerase chain reaction and quantitative real-time polymerase chain reaction.
Two common methods for the detection of PCR in real-time PCR are non-specific fluorescent dyes that intercalate with any double-stranded DNA and sequence-specific DNA probes consisting of oligonucleotides that are labelled with a fluorescent reporter. The procedure is used in forensic, research and diagnostic purposes. The term qPCR reagents market defines the market for reagents used in real-time PCR.
The rise of the qPCR Reagents is mainly driven by factors such as rise in patient population for genetic disorders and infectious diseases, the rise in the geriatric population, and the advancements in technology related to the field. The other major factors boosting the growth are increasing public and private funding, grants and investments for studies on PCR.
The market remains restricted by technical restrictions related to qPCR and the high costs associated with it.
This research report has been segmented and sub-segmented into the following categories:
Leading companies in the Europe qPCR Reagents market are Thermo Fisher Scientific, Bio-Rad Laboratories, Qiagen N.V., F. Hoffmann-La Roche, Agilent Technologies Inc., Takara Bio, Affymetrix Inc., Promega Corporation, Sigma-Aldrich Corporation, and Quanta Biosciences.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 Detection Method
5.1.1 Introduction
5.1.2 Dye-Based qPCR Reagents
5.1.3 Probes and Primer-Based qCPR Reagents
5.1.4 Y-o-Y Growth Analysis, By Detection Method
5.1.5 Market Attractiveness Analysis, By Detection Method
5.1.6 Market Share Analysis, By Detection Method
5.2 Packaging Type
5.2.1 Introduction
5.2.2 qPCR Core Kits
5.2.3 qCPR Mastermixes
5.2.5 Y-o-Y Growth Analysis, By Packaging Type
5.2.6 Market Attractiveness Analysis, By Packaging Type
5.2.7 Market Share Analysis, By Packaging Type
5.3 End User
5.3.1 Introduction
5.3.2 Hospitals & Diagnostic Centre
5.3.3 Research Laboratories & Academic Institutes
5.3.4 Pharmaceutical and Biotechnoloy Companies
5.3.5 Clinical Research Organizations
5.3.6 Forensic Laboratories
5.3.7 Y-o-Y Growth Analysis, By End User
5.3.8 Market Attractiveness Analysis, By End User
5.3.9 Market Share Analysis, By End User
5.4 Application
5.4.1 Introduction
5.4.2 Diagnostic
5.4.3 Research
5.4.4 Forensic
5.4.5 Y-o-Y Growth Analysis, By Applications
5.4.6 Market Attractiveness Analysis, By Applications
5.4.7 Market Share Analysis, By Applications
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Detection Method
6.1.3.3 By Packaging Type
6.1.3.4 By End User
6.1.3.5 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Detection Method
6.1.4.3 By Packaging Type
6.1.4.4 By End User
6.1.4.5 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Detection Method
6.1.5.3 By Packaging Type
6.1.5.4 By End User
6.1.5.5 By Application
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.1 Thermo Fisher Scientific
8.1.1 Overview
8.1.2 Detection Method Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Bio-Rad Laboratories
8.3 Qiagen NV
8.4 F. Hoffman-La Roche
8.5 Agilent Technologies
8.6 Takara Bio
8.7 Affymetrix
8.8 Promege Corporation
8.9 Sigma-Aldrich Corporation
8.10 Quanta Biosciences
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
Appendix
Related Reports
